SLC5A2 and type 2 diabetes mellitus: Moreover, research has shown that SGLT2 inhibitors could prevent the development of endothelial dysfunction and delay vascular aging in animal models of T2DM by reducing glucose toxicity, oxidative stress and inflammation, and improving the viability of hyperglycemic endothelial cells [61].